UnknownNot Applicable

Radiation Pneumonitis After SBRT for NSCLC

Norway105 participantsStarted 2013-10

Plain-language summary

Aims: 1. Evaluate changes in lung function before and after radiotherapy for patients with NSCLC in stage I-III receiving curatively intended radiotherapy 2. To assess the predictive value of pulmonary function tests for the development of radiation pneumonitis after curative radiotherapy 3. To assess biomarkers in blood samples before, during, and after radiotherapy and correlate to the development of radiation pneumonitis 4. Investigate survival

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 18 years old * Current lung cancer, not older than 8 weeks * Received written consent * Non small cell lung cancer * Stage IA-IIIA * Inoperable Exclusion Criteria: * Lack of consent * Operable * Additional cancer disease * Small cell lung carcinoma or neuroendocrine lung cancer

What they're measuring

permanently reduced lung function

Timeframe: 2 years

Trial details

NCT IDNCT02428049

SponsorSykehuset i Vestfold HF

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-12

View on ClinicalTrials.gov More Lung Cancer trials